Our research project focuses on developing innovative cancer treatments using synthetic biology. We aim to address the urgent need for more effective therapies. We will create two research platforms: nanobodies that effectively target and mark cancer cells for immune system attack, and light-controllable molecular tools for the precise regulation of cancer cell genes, thereby reducing tumor growth and enhancing the immune response against cancer. Our methods include protein engineering, cell culture experiments, and studies using humanized animal models to assess our approaches. Conducted at the Faculty of Medicine at the University of Helsinki, this research aims to develop cancer treatments with enhanced efficacy and reduced side effects, improving patient outcomes and alleviating the burden of cancer treatment. By showcasing the potential of synthetic biology, we seek to develop smarter, safer therapies that can transform treatment paradigms and advance biomedicine.

2026

2031